Mohs micrographic surgery

American Family Physician

Volumn 72, Issue 5, 2005, Pages 845-848

  Bowen, Glen M ^a,b   White Jr , George L ^a   Gerwels, John W ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Huntsman Cancer Institute ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY SURGERY; BASAL CELL CARCINOMA; BLEEDING; CANCER SURGERY; CHEMOSURGERY; FROZEN SECTION; GRAFT FAILURE; HEMATOMA; HISTOPATHOLOGY; HUMAN; INTERPOLATION FLAP; LOCAL ANESTHESIA; POSTOPERATIVE COMPLICATION; PRIMARY WOUND CLOSURE; RADIOTHERAPY; REVIEW; SECONDARY INTENT WOUND HEALING; SKIN CANCER; SKIN FLAP; SKIN GRAFT; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TISSUE NECROSIS; TREATMENT INDICATION; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; WOUND CLOSURE; WOUND HEALING;

HUMANS; MOHS SURGERY; SKIN NEOPLASMS;

EID: 24344460828     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Mohs FE. Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg 1941;42;279-95.
2. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:1177-83.
3. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28.
4. Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998;39(5 pt 1):698-703.
5. Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 2003;48:233-7.
6. Griego RD, Zitelli JA. Intra-incisional prophylactic antibiotics for dermatologic surgery. Arch Dermatol 1998;134:688-92.
7. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001 [published correction appears in CA Cancer J Clin 2001;51:144]. CA Cancer J Clin 2001;51:15-36.
8. American Cancer Society homepage. Accessed online August 8, 2005, at: http://www.cancer.org/docroot/home/index.asp.
9. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: basal cell and squamous cell skin cancers. Version 1.2005. Accessed online August 8, 2005, at: http://www.nccn.org/professionals/physician_gls/PDF/ nmsc.pdf.
10. Hruza GJ. Mohs micrographic surgery. Otolaryngol Clin North Am 1990;23:845-64.
11. Bieley HC, Kirsner RS, Reyes BA, Garland LD. The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma. J Am Acad Dermatol 1992;26(5 pt 1):754-6.
12. Lambert DR, Siegle RJ. Skin cancer: a review with consideration of treatment options including Mohs micrographic surgery. Ohio Med 1990;86:745-7.
13. Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol 1991;17:574-8.
14. Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, et al. Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol 1995;33(2 pt 1):271-8.
15. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr. Mohs micrographic surgery. J Am Acad Dermatol 1998;39:79-97.
16. Lang PG Jr, Osguthorpe JD. Indications and limitations of Mohs micrographic surgery. Dermatol Clin 1989;7:627-44.
17. The complete library of NCCN clinical practice guidelines in oncology. Rockledge, Pa.: National Comprehensive Cancer Network, 2003. Accessed online August 8, 2005, at: http://www.nccn.org/professionals/physician_gls/default.asp.
18. Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004;77:574-9.